Dr. Farley's research focuses on the impact of Medicaid prescription managed care policies on economic and clinical outcomes in vulnerable patient populations. Currently, he is examining Medicaid data to assess the effect of prescription benefit changes on patterns of care for individuals with schizophrenia.